CAS 94161-10-1

Hepoxilin B

Controlled Product

CAS: 94161-10-1

Applications Hepoxilin B is a major eicosanoid produced in the human epidermis and is incorporated onto phospholipids in psoriatic lesions of human epidermis fragments and epidermal cells.
References Anton, R., et. al.: J. Investigative Dermatology, 118, 139 (2002)

Formula: C₂₀H₃₂O₄

Color and Shape: Neat

Molecular weight: 336.47

Ref: TR-H265720

Hepoxilin B-d11

CAS: 94161-10-1

Hepoxilin B-d11 is a potent inhibitor of human and Chinese cancer cell growth. It works by inhibiting protein kinases, which are enzymes that play a critical role in the regulation of cellular processes such as apoptosis and tumor growth. Hepoxilin B-d11 is an analog of urinary Hepoxilin B, a natural product with medicinal properties. This anticancer drug has shown promising results in preclinical studies as a potential treatment for various types of cancer. Its ability to inhibit kinases makes it an attractive candidate for combination therapy with other kinase inhibitors, which can increase its efficacy against cancer cells. Overall, Hepoxilin B-d11 holds great promise as a novel therapeutic option for cancer treatment.

Formula: C₂₀H₃₂O₄

Purity: Min. 95%

Molecular weight: 336.5 g/mol

Ref: 3D-UDA16110

Hepoxilin B3

CAS: 94161-10-1

Formula: C₂₀H₃₂O₄

Molecular weight: 336.47

Ref: 4Z-H-075001